Expired contract
Blood Group Genotyping for Sickle Cell and Thalassaemi
Details
- Buyer
- NHS England
- Supplier(s)
- NHS Blood and transplant (NHS030)
- Value
- GBP 140,671
- Duration
- 11 months
- Topic
- Blood analysis services
- Published
- 3 September 2025
- Source
- uk:contracts_finder
Tender description
The main output of this programme is for blood group genotyping to become embedded into routine practice. Primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping.
Timeline
- Completed: Award date12 May 2025
- Completed: Award published3 September 2025Current notice
- Completed: Contract expiry date31 March 2026
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 85111810 · Blood analysis services
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
3 similar open tenders
See more open tenders related to Blood Group Genotyping for Sickle Cell and Thalassaemi.
- Open tender
Public Healthcare - Outsourcing DPS
- Open tender
Public Healthcare - Outsourcing DPS
Related buyers
Buyers similar to NHS England.
BuyersCountValue
- 461£2.1bn
- 372£250.0m
- 362£15.0bn
- 294£2.8bn
- 267£19.9bn
- 263£902.6m
- 250£511.2m
- 203£1.0bn
- 142£900.0m
- 122£59.9m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
